-transparent.png){kind=logo}
Taxol is a novel and promising oncolytic agent the use of which is hampered by its neurotoxicity. We now describe a taxol-induced neuropathy in rats and its prevention by the adrenocorticotropic hormone-(4-9) (ACTH-(4-9)) analog, ORG 2766. A decrease in sensory nerve conduction velocity was seen in taxol-treated rats, both with daily injections of small amounts (6 mg/kg per week) and with weekly injections of higher amounts (9 mg/kg per week) of taxol. Concomitant administration of ORG 2766 completely prevented the occurrence of a neuropathy.
Related Publications
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
September 1990,
European journal of pharmacology,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
May 1983,
Life sciences,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
January 1989,
Psychopharmacology bulletin,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
September 1994,
International journal of oncology,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
January 1976,
Pharmacology, biochemistry, and behavior,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
July 1979,
Physiology & behavior,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
January 1982,
Peptides,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
March 1984,
Life sciences,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
April 1997,
Brain research. Developmental brain research,
F P Hamers, and
C Pette, and
J P Neijt, and
W H Gispen
January 1986,
Peptides,
